China Aoxing Pharmaceutical hires new CFO

China Aoxing Pharmaceutical, a pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, has appointed Dr. Hui Shao as CFO, effective immediately.


Dr. Shao, who was a scientist before jumping into finance and investment arena, has has 14 years of extensive financial, accounting, private investment and strategic business development experience across various aspects of the global healthcare industry.


With Dr. Shao's appointment, Hongyue Hao will step down as the Acting CFO. Hao will continue to be the Vice General Manager of Financial Operations and Reporting of Hebei Aoxing Pharmaceutical Group Company, Inc., the main operating subsidiary of China Aoxing.

Suggested Articles

Some of you might have already been aware of the news that Questex—with the aim to focus on event business—will shut down permanently all media brands in Asia…

Some advice for transitioning into an advisory role

Global risks are intensifying but the collective will to tackle them appears to be lacking. Check out this report for areas of concern